Parametric Portfolio Associates’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $2.3M | Buy |
72,994
+19,018
| +35% | +$600K | ﹤0.01% | 2344 |
|
|
2021
Q4 | $2.18M | Buy |
53,976
+24,059
| +80% | +$973K | ﹤0.01% | 2387 |
|
|
2021
Q3 | $1.04M | Buy |
29,917
+145
| +0.5% | +$5.06K | ﹤0.01% | 2795 |
|
|
2021
Q2 | $818K | Sell |
29,772
-4,873
| -14% | -$134K | ﹤0.01% | 2857 |
|
|
2021
Q1 | $973K | Buy |
34,645
+5,335
| +18% | +$150K | ﹤0.01% | 3175 |
|
|
2020
Q4 | $761K | Buy |
29,310
+7,973
| +37% | +$207K | ﹤0.01% | 3184 |
|
|
2020
Q3 | $366K | Sell |
21,337
-29,869
| -58% | -$512K | ﹤0.01% | 3404 |
|
|
2020
Q2 | $1.27M | Buy |
51,206
+34,584
| +208% | +$856K | ﹤0.01% | 2788 |
|
|
2020
Q1 | $231K | Buy |
+16,622
| New | +$231K | ﹤0.01% | 3490 |
|